AlzeCure Pharma
1.40 SEK
0.00 %
Less than 1K followers
ALZCUR
First North Stockholm
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
0.00 %
-2.79 %
-28.46 %
-30.25 %
-29.37 %
-41.04 %
-65.86 %
-75.07 %
-85.27 %
AlzeCure Pharma is a pharmaceutical company that researches and develops small molecule drug candidates for the treatment of diseases of the central nervous system, with a particular focus on Alzheimer's and chronic pain. The company is developing several parallel projects where the technology and research are based on its own drug platform. AlzeCure Pharma is headquartered in Huddinge, Sweden.
Read moreMarket cap
160.31M SEK
Turnover
116.27K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
26/8
2026
Interim report Q2'26
11/11
2026
Interim report Q3'26
23/2
2027
Annual report '26
All
Press releases
3rd party
ShowingAll content types
AlzeCure Pharma to host live seminar on the pain project TrkA-NAM ACD137 with a focus on osteoarthritis and neuropathic pain
AlzeCure Pharma to present at Redeye Investor Forum Online on May 21
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools